KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.31 $2.47 Thursday, 25th Apr 2024 AKBA stock ended at $1.33. This is 2.92% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.05% from a day low at $1.31 to a day high of $1.35.
90 days $1.31 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jul 10, 2023 $1.04 $1.25 $1.02 $1.21 2 717 248
Jul 07, 2023 $0.88 $1.05 $0.87 $1.02 2 020 580
Jul 06, 2023 $0.85 $0.87 $0.82 $0.87 2 284 230
Jul 05, 2023 $0.90 $0.90 $0.86 $0.87 2 239 499
Jul 03, 2023 $0.93 $0.93 $0.90 $0.90 657 034
Jun 30, 2023 $0.93 $0.94 $0.90 $0.92 884 575
Jun 29, 2023 $0.93 $0.95 $0.91 $0.93 1 314 493
Jun 28, 2023 $0.94 $0.97 $0.92 $0.94 812 775
Jun 27, 2023 $0.92 $0.97 $0.91 $0.93 1 680 352
Jun 26, 2023 $1.01 $1.01 $0.90 $0.91 3 321 516
Jun 23, 2023 $1.07 $1.07 $0.99 $1.02 1 789 741
Jun 22, 2023 $1.06 $1.09 $1.02 $1.05 1 305 540
Jun 21, 2023 $1.13 $1.17 $1.07 $1.09 2 318 997
Jun 20, 2023 $1.12 $1.14 $1.11 $1.13 2 244 317
Jun 16, 2023 $1.14 $1.18 $1.10 $1.11 1 796 326
Jun 15, 2023 $1.18 $1.23 $1.13 $1.14 1 866 726
Jun 14, 2023 $1.24 $1.28 $1.18 $1.18 1 295 717
Jun 13, 2023 $1.26 $1.27 $1.20 $1.23 1 657 743
Jun 12, 2023 $1.30 $1.35 $1.24 $1.26 2 073 828
Jun 09, 2023 $1.25 $1.27 $1.22 $1.26 958 916
Jun 08, 2023 $1.33 $1.33 $1.23 $1.25 1 093 018
Jun 07, 2023 $1.22 $1.32 $1.21 $1.28 3 335 197
Jun 06, 2023 $1.12 $1.23 $1.12 $1.20 1 876 774
Jun 05, 2023 $1.12 $1.15 $1.07 $1.12 1 681 251
Jun 02, 2023 $1.12 $1.17 $1.07 $1.10 1 746 673
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT